Insider trade

Disc Medicine (IRON): Director sold ~$1.11M

Kevin Bitterman, Director at Disc Medicine, sold ~$1.11M of Disc Medicine shares.

~$1.11M
Approx. value · 14K sh @ $80.23
296K
Holds after · shares reported
Traded
Oct 21, 2026
Filed
Oct 21, 2026

What stands out in this filing

  • The sale was 4.4% of the shares this insider held before it; the filing reports 296,277 shares, held indirectly afterwards.
  • 13,783 shares at an average of $80.23 each, as reported on the form.
  • Footnote references a pre-arranged trading plan (Rule 10b5-1).

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 19, 2026Company filing · Form 8-K · Material agreement, ResultsSigned an important agreement, and reported its results (and 1 more item)
  2. Oct 19, 2026Insider · 1 personInsiders: 3 sales (~$879K)
  3. Oct 20, 2026Insider · 1 personInsiders: 3 sales (~$425K)
  4. Oct 21, 2026 · this disclosureInsiderDirector sold ~$1.11M of IRON shares in the open market

What came next

  1. Oct 21, 2026Insider · 1 personInsiders: 2 sales (~$942K)
  2. Oct 26, 20265% stakeAI DMI LLC filed an activist stake (13D) of 6.6%
  3. Nov 5, 2026Company filing · Form 8-K · ResultsReported its results
  4. Nov 10, 2026Insider · Their largest sale since 2023Officer sold ~$1.36M of IRON shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Disc Medicine

For Disc Medicine, OQRO holds 23 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IRON page.

Other recent filings by Kevin Bitterman, Director

The full history of Kevin Bitterman, Director is on the profile page.

How this filing works

Explore the data

Common questions

Which Disc Medicine (IRON) insider traded, and how much?

Kevin Bitterman, Director at Disc Medicine, sold ~$1.11M of Disc Medicine shares. 14K shares at $80.23.

When did it happen, and when was it made public?

Traded: Oct 21, 2026. Filed: Oct 21, 2026.

What stands out in this filing?

The sale was 4.4% of the shares this insider held before it; the filing reports 296,277 shares, held indirectly afterwards. 13,783 shares at an average of $80.23 each, as reported on the form. Footnote references a pre-arranged trading plan (Rule 10b5-1).

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Disc Medicine recently?

For Disc Medicine, OQRO holds 23 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the IRON page.

Does this mean IRON stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Disc Medicine

Everything OQRO holds on this company is on its IRON page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data